Wugen is a clinical-stage biotechnology company developing the next generation of off-the-shelf memory natural killer (NK) and CAR-T cell therapies for cancer. Wugen is leveraging its proprietary Moneta platform and deep genomic engineering expertise to pioneer a new class of memory NK cell therapies to treat hematological and solid tumor malignancies. Wugen is based out of St. Louis, Missouri and San Diego, California.
View Top Employees from Wugen| Website | http://www.wugen.com |
| Employees | 92 (92 on RocketReach) |
| Founded | 2018 |
| Address | 4260 Forest Park Ave Suite 100, St. Louis, Missouri 63108, US |
| Technologies |
JavaScript,
HTML,
PHP
+25 more
(view full list)
|
| Industry | Biotechnology, Biotechnology Research, Other Healthcare Technology Systems, Science and Engineering, Therapeutics, Health Care |
Looking for a particular Wugen employee's phone or email?
Wugen Questions
Kumar Srinivasan is the CEO of Wugen.
92 people are employed at Wugen.
Wugen is based in St. Louis, Missouri.
Top Wugen Employees
-
5+5
-
1
-
44
-
31
-
23
-
View
Kenneth Jacobs
VP Pharmacovigilance and Clinical Development at Wugen
Gaithersburg, Maryland, United States15+ -
55
-
55
Related Companies
